Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Cash Flow Reinvestment Rate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Cash Flow Reinvestment Rate of 0.48x as of September 2025, reinvesting CN¥56.87 Million (capex CN¥56.87 Million ) from operating cash flow of CN¥117.38 Million. See 600436 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2001–2025)
Historical reinvestment intensity for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see 600436 cash flow conversion.
Annual Cash Flow Reinvestment Rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Year-by-year capital reinvestment analysis for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. See 600436 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.00x | CN¥539.00 Million | CN¥77.03 Million | CN¥339.80 Million | ▲ +617.2% |
| 2024 | 0.98x | CN¥1.28 Billion | CN¥1.31 Billion | CN¥1.07 Billion | ▼ -3.0% |
| 2023 | 1.01x | CN¥2.22 Billion | CN¥2.21 Billion | CN¥141.87 Million | ▲ +8.9% |
| 2022 | 0.92x | CN¥6.35 Billion | CN¥6.87 Billion | CN¥175.37 Million | ▲ +81.2% |
| 2021 | 0.51x | CN¥235.49 Million | CN¥462.27 Million | CN¥92.17 Million | ▲ +72.2% |
| 2020 | 0.30x | CN¥434.05 Million | CN¥1.47 Billion | CN¥419.01 Million | ▲ +139.9% |
| 2018 | 0.12x | CN¥75.52 Million | CN¥612.31 Million | CN¥74.24 Million | ▼ -37.6% |
| 2017 | 0.20x | CN¥133.69 Million | CN¥676.93 Million | CN¥51.87 Million | ▼ -78.9% |
| 2016 | 0.94x | CN¥369.26 Million | CN¥394.54 Million | CN¥90.97 Million | ▲ +140.9% |
| 2015 | 0.39x | CN¥118.68 Million | CN¥305.51 Million | CN¥78.86 Million | ▲ +297.3% |
| 2014 | 0.10x | CN¥25.87 Million | CN¥264.50 Million | CN¥25.87 Million | ▼ -81.7% |
| 2013 | 0.53x | CN¥146.54 Million | CN¥274.34 Million | CN¥146.54 Million | ▼ -44.1% |
| 2012 | 0.96x | CN¥155.22 Million | CN¥162.40 Million | CN¥155.22 Million | ▲ +526.1% |
| 2011 | 0.15x | CN¥35.56 Million | CN¥232.95 Million | CN¥35.56 Million | ▼ -19.4% |
| 2010 | 0.19x | CN¥38.90 Million | CN¥205.41 Million | CN¥38.90 Million | ▼ -17.3% |
| 2009 | 0.23x | CN¥29.67 Million | CN¥129.52 Million | CN¥29.67 Million | ▼ -95.1% |
| 2008 | 4.65x | CN¥58.50 Million | CN¥12.57 Million | CN¥58.50 Million | ▲ +162.4% |
| 2007 | 1.77x | CN¥106.47 Million | CN¥60.04 Million | CN¥106.47 Million | ▲ +932.2% |
| 2006 | 0.17x | CN¥8.71 Million | CN¥50.70 Million | CN¥8.71 Million | ▼ -65.6% |
| 2005 | 0.50x | CN¥34.54 Million | CN¥69.06 Million | CN¥34.54 Million | ▲ +358.9% |
| 2004 | 0.11x | CN¥10.75 Million | CN¥98.67 Million | CN¥10.75 Million | ▼ -77.3% |
| 2003 | 0.48x | CN¥15.56 Million | CN¥32.36 Million | CN¥15.56 Million | ▲ +419.2% |
| 2002 | 0.09x | CN¥9.77 Million | CN¥105.45 Million | CN¥9.77 Million | ▼ -47.6% |
| 2001 | 0.18x | CN¥11.64 Million | CN¥65.84 Million | CN¥11.64 Million | — |